Skip to main content
SpringerLink
Log in

Value of magnetic resonance imaging in prostate cancer diagnosis

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

MRI has shown its potential in prostate cancer (PCa) imaging. MRI is able to demonstrate zonal anatomy with excellent contrast resolution. Furthermore it can detect PCa dependent not only on tumor-size, histological grading, PSA levels, but also on technical equipment and reader’s experience. Non-palpable PCas in the inner and outer gland can be detected by this technique. Another potential is that MRI is helpful for tumor staging and treatment planning as well as response evaluation. Besides the morphological information, MRI can give functional information based on metabolic evaluation with proton magnetic resonance spectroscopy and of tumor angiogenesis based on dynamic contrast-material enhanced MRI and diffusion-weighted imaging. In addition MRI can be used for targeted prostate biopsies; however, the clinical practicability is questionable. Furthermore many data about the value of MRI for PCa diagnosis are based on transrectal ultrasound (TRUS) biopsy findings. Since there is lack of accuracy in fusing MRI images with TRUS images these limit the results of MRI for cancer diagnosis. However, in the future MRI may play an additional role in planning and monitoring minimally invasive PCa therapies. Although, MRI of the prostate seems to be useful, nevertheless this method remains expensive and lacks availability regarding the oncoming requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Pallwein L, Mitterberger M, Struve P et al (2007) Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. Eur Radiol [Mar 7; Epub ahead of print]

  2. Chen ME, Troncoso P, Johnston DA, Tang K, Babaian RJ (1997) Optimization of prostate biopsy strategy using computer based analysis. J Urol 158:2168–2175

    Article  PubMed  CAS  Google Scholar 

  3. Motulsky H (1995) Intuitive biostatistics. Oxford University Press, New York, p 129

    Google Scholar 

  4. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C (1997) The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50:562–566

    Article  PubMed  CAS  Google Scholar 

  5. Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30(1):5–13

    Article  PubMed  CAS  Google Scholar 

  6. Choi YJ, Kim JK, Kim N et al (2007) Functional MR imaging of prostate cancer. RadioGraphics 27:63–75

    PubMed  Google Scholar 

  7. Beyersdorff D, Winkel A, Hamm B et al (2005) MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 234(2):576–581. Epub 2004 Dec 22

    Article  PubMed  Google Scholar 

  8. Brown TR, Kincaid BM, Ugurbil K (1982) NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 79:3523–3526

    Article  PubMed  CAS  Google Scholar 

  9. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB (1997) Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 38:311–321

    Article  PubMed  CAS  Google Scholar 

  10. Claus FG, Hricak H, Hattery RR (2004) Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 24:S167–S180

    Article  PubMed  Google Scholar 

  11. Futterer JJ, Engelbrecht MR, Jager GJ et al (2007) Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal-pelvic phased-array coils : local staging accuracy of prostate cancer using endorectal coil MR imaging. Eur Radiol 17(4):1055–1065

    Article  PubMed  Google Scholar 

  12. Kurhanewicz J, Vigneron DB, Hricak H, Navayan P, Carroll P, Nelson SJ (1996) Three-dimensional 1H MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7 cm3) spatial resolution. Radiology 198:795–805

    PubMed  CAS  Google Scholar 

  13. Schnall MD, Pollack HM (1990) Magnetic resonance imaging of the prostate. Urol Radiol 12:109–114

    Article  PubMed  CAS  Google Scholar 

  14. Ikonen S, Kivisaari L, Vehmas T et al (2001) Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 42:70–73

    Article  PubMed  CAS  Google Scholar 

  15. White S, Hricak H, Forstner R et al (1995) Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 195:385–390

    PubMed  CAS  Google Scholar 

  16. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO (2002) Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 12:2294–2302

    PubMed  Google Scholar 

  17. Bartolozzi C, Menchi I, Lencioni R et al (1996) Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens. Eur Radiol 6(3):339–345

    Article  PubMed  CAS  Google Scholar 

  18. Cornud F, Flam T Chauvenic L et al (2002) Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224(1):203–210

    Article  PubMed  Google Scholar 

  19. Ikonen S, Karkkainen P, Kivisaari L et al (1998) Magnetic resonance imaging of clinically localized prostatic cancer. J Urol 159(3):915–919

    Article  PubMed  CAS  Google Scholar 

  20. Ikonen S, Karkkainen P, Kivisaari L et al (2001) Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 11(2):236–241

    Article  PubMed  CAS  Google Scholar 

  21. May F, Treumann T, Dettmar P et al (2001) Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 87(1):66–69

    Article  PubMed  CAS  Google Scholar 

  22. Perrotti M, Kaufman RP, Jennings TA et al (1996) Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol 156(1):106–109

    Article  PubMed  CAS  Google Scholar 

  23. Presti JC, Hricak H, Narayan PA et al (1996) Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR Am J Roentgenol 166(1):103–108

    PubMed  Google Scholar 

  24. Rorvik J, Halvorsen OJ, Albrektsen G et al (1999) MRI with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 9(1):29–34

    Article  PubMed  CAS  Google Scholar 

  25. Yu KK, Hricak H, Alagappan R et al (1997) Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202(3):697–702

    PubMed  CAS  Google Scholar 

  26. Mullerad M, Hricak H, Kuroiwa K et al (2005) Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174(6):2158–2163

    Article  PubMed  Google Scholar 

  27. Akin O, Sala E, Moskowitz CS et al (2006) Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 239(3):784–792

    Article  PubMed  Google Scholar 

  28. Pelzer AE, Bektic J, Berger AP et al (2005) Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project. Eur Urol 48(6):916–921 discussion 921

    Article  PubMed  Google Scholar 

  29. Hricak H (2005) MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 78(Spec No 2):S103–S111

    Article  PubMed  Google Scholar 

  30. Males RG, Vigneron DB, Star-Lack J et al (2000) Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 43:17–22

    Article  PubMed  CAS  Google Scholar 

  31. Scheidler J, Hricak H, Vigneron DB et al (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging—clinicopathologic study. Radiology 213:473–480

    PubMed  CAS  Google Scholar 

  32. Zakian KL, Eberhardt S, Hricak H et al (2003) Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging—initial results. Radiology 229:241–247

    Article  PubMed  Google Scholar 

  33. Prando A, Kurhanewicz J, Borges AP et al (2005) Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236(3):903–910

    Article  PubMed  Google Scholar 

  34. Coakley FV, Kurhanewicz J, Lu Y et al (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223(1):91–97

    Article  PubMed  Google Scholar 

  35. Qayyum A, Coakley FV, Lu Y et al (2002) Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223(1):91–97

    Article  Google Scholar 

  36. Brassell SA, Krueger WR, Choi JH, Taylor JA 3rd (2004) Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage. World J Urol 22(4):289–292

    Article  PubMed  Google Scholar 

  37. Beer M, Schmidt H, Riedl R (1989) The clinical value of preoperative staging of bladder and prostatic cancers with nuclear magnetic resonance and computerized tomography. Urologe A 28(2):65–69

    PubMed  CAS  Google Scholar 

  38. Bezzi M, Kressel HY, Allen KS et al (1988) Prostatic carcinoma: staging with MR imaging at 1.5 T. Radiology 169(2):339–346

    PubMed  CAS  Google Scholar 

  39. Jager GJ, Barentsz JO, Oosterhof GO et al (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence. AJR Am J Roentgenol 167(6):1503–1507

    PubMed  CAS  Google Scholar 

  40. Kier R, Wain S, Troiano R (1993) Fast spin-echo MR images of the pelvis obtained with a phased-array coil: value in localizing and staging prostatic carcinoma. AJR Am J Roentgenol 161(3):601–606

    PubMed  CAS  Google Scholar 

  41. Nicolas V, Beese M, Keulers A et al (1994) MR tomography in prostatic carcinoma: comparison of conventional and endorectal MRT. Rofo 161(4):319–326

    PubMed  CAS  Google Scholar 

  42. Tuzel E, Sevinc M, Obuz F et al (1998) Is magnetic resonance imaging necessary in the staging of prostate cancer? Urol Int 61:227–231

    Article  PubMed  CAS  Google Scholar 

  43. Harisinghani MG, Barentsz J, Hahn PF et al (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348(25):2491–9 Erratum in: N Engl J Med. 2003;349(10):1010

    Article  PubMed  Google Scholar 

  44. Zakian KL, Sircar K, Hricak H et al (2005) Correlation of proton MR spectrosocpic imaging with gleason score grade based on step-section pathology after radical prostatectomy. Radiology 234:804–814

    Article  PubMed  Google Scholar 

  45. Stamey TA, McNeal JE, Freiha FS, Redwine E (1988) Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 139(6):1235–1241

    PubMed  CAS  Google Scholar 

  46. Bostwick DG, Graham SD Jr, Napalkov P et al (1993) Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology 41(5):403–411

    Article  PubMed  CAS  Google Scholar 

  47. McNeal JE, Villers AA, Redwine EA et al (1990) Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 14(3):240–247

    Article  PubMed  CAS  Google Scholar 

  48. Yu KK, Scheidler J, Hricak H et al (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488

    PubMed  CAS  Google Scholar 

  49. Mullerad M, Hricak H, Wang L, Chen HN, Kattan MW, Scardino PT (2004) Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. Radiology 232:140–146

    Article  PubMed  Google Scholar 

  50. Latchamsetty KC, Borden LS Jr, Porter CR et al (2007) Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve? Can J Urol 14:3429–3434

    PubMed  Google Scholar 

  51. Choyke PL (2005) Contrast agents for imaging tumor angiogenesis: is bigger better? Radiology 235(1):1–2

    Article  PubMed  Google Scholar 

  52. Buckley DL, Roberts C, Parker GJ et al (2004) Prostate cancer: evaluation of vascular characteristics with dynamic contrast enhanced T1-weighted MR imaging—initial experience. Radiology 233:709–715

    Article  PubMed  Google Scholar 

  53. Brix G, Semmler W, Port R et al (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MRI. J Comput Assist Tomogr 15:621–628

    Article  PubMed  CAS  Google Scholar 

  54. Hofmann U, Brix G, Knopp MV et al (1995) Pharmacokinetic mapping of the breast: a new method for dynamic MR-mammography. Magn Reson Med 33:506–514

    Article  Google Scholar 

  55. Hawighorst H, Knopp MV, Debus J et al (1998) Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging 8:783–788

    Article  PubMed  CAS  Google Scholar 

  56. Port RE, Knopp MV, Hoffmann U et al (1999) Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 10:233–241

    Article  PubMed  CAS  Google Scholar 

  57. Engelbrecht MR, Huisman HJ, Laheij RJet al (2003) Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229(1):248–254

    Article  PubMed  Google Scholar 

  58. Kim JK, Hong SS, Choi YJ et al (2005) Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging 22:639–646

    Article  PubMed  CAS  Google Scholar 

  59. Tien RD, Felsberg GJ, Friedman H et al (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162(3):671–677

    PubMed  CAS  Google Scholar 

  60. Eis M, Els T, Hoehn-Berlage M (1995) High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med 34(6):835–844

    Article  PubMed  CAS  Google Scholar 

  61. Eis M, Els T, Hoehn-Berlage M, Hossmann KA (1994) Quantitative diffusion MR imaging of cerebral tumor and edema. Acta Neurochir Suppl (Wien) 60:344–346

    CAS  Google Scholar 

  62. Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9(1):53–60

    Article  PubMed  CAS  Google Scholar 

  63. Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 22(1):60–64

    PubMed  CAS  Google Scholar 

  64. Shimofusa R, Fujimoto H, Akamata H et al (2005) Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 29(2):149–153

    Article  PubMed  Google Scholar 

  65. Anastasiadis AG, Lichy MP, Nagele U et al (2006) MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 50:738–748

    Article  PubMed  CAS  Google Scholar 

  66. Zangos S, Eichler K, Engelmann K et al (2005) MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol 15:174–182

    Article  PubMed  Google Scholar 

  67. Hricak H, Wang L, Wei DC et al (2004) The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 100:2655–2663

    Article  PubMed  Google Scholar 

  68. Sella T, Schwartz LH, Swindle PW et al (2004) Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 231(2):379–385

    Article  PubMed  Google Scholar 

  69. Silverman JM, Krebs TL (1997) MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. AJR Am J Roentgenol 168(2):379–385

    PubMed  CAS  Google Scholar 

  70. D’Amico AV, Whittington R, Malkowicz B et al (2000) Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 164:759–763

    Article  PubMed  CAS  Google Scholar 

  71. Wefer AE, Hricak H, Vigneron DB et al (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404

    Article  PubMed  CAS  Google Scholar 

  72. Heuck A, Scheidler J, Sommer B, Graser A, Muller-Lisse UG, Massmann J (2003) MR imaging of prostate cancer. Radiologe 43:464–473

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Radiology II/Uroradiology, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria

    Friedrich Aigner, Leo Pallwein, Dieter zur Nedden & Ferdinand Frauscher

  2. Department of Urology, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria

    Alexandre Pelzer & Georg Bartsch

  3. Department of Pathology, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria

    Georg Schaefer

Authors
  1. Friedrich Aigner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leo Pallwein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alexandre Pelzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georg Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Georg Bartsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dieter zur Nedden
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ferdinand Frauscher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Friedrich Aigner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aigner, F., Pallwein, L., Pelzer, A. et al. Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol 25, 351–359 (2007). https://doi.org/10.1007/s00345-007-0187-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-007-0187-2

Keywords

Search

Navigation